Lachlan Brown
Stock Analyst at Rothschild & Co
(1.62)
# 3,420
Out of 5,182 analysts
14
Total ratings
45.45%
Success rate
-1.84%
Average return
Main Sectors:
Stocks Rated by Lachlan Brown
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPSC SPS Commerce | Downgrades: Neutral | $100 → $60 | $57.91 | +3.61% | 2 | Apr 16, 2026 | |
| DSGX The Descartes Systems Group | Upgrades: Buy | $100 → $90 | $75.28 | +19.55% | 2 | Apr 16, 2026 | |
| EPRX Eupraxia Pharmaceuticals | Initiates: Outperform | n/a | $7.06 | - | 1 | Mar 23, 2026 | |
| VRDN Viridian Therapeutics | Initiates: Outperform | n/a | $14.33 | - | 1 | Dec 3, 2025 | |
| MANH Manhattan Associates | Downgrades: Neutral | $270 → $200 | $142.88 | +39.98% | 2 | Jun 10, 2025 | |
| HROW Harrow | Initiates: Outperform | n/a | $39.14 | - | 1 | Jun 10, 2025 | |
| KLRS Kalaris Therapeutics | Initiates: Outperform | n/a | $6.33 | - | 1 | Apr 8, 2025 | |
| OCUL Ocular Therapeutix | Initiates: Outperform | n/a | $9.66 | - | 1 | Apr 8, 2025 | |
| SNPS Synopsys | Initiates: Buy | $600 | $477.26 | +25.72% | 1 | Jan 13, 2025 | |
| CDNS Cadence Design Systems | Initiates: Buy | $350 | $331.61 | +5.55% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $40.89 | - | 1 | Oct 16, 2024 |
SPS Commerce
Apr 16, 2026
Downgrades: Neutral
Price Target: $100 → $60
Current: $57.91
Upside: +3.61%
The Descartes Systems Group
Apr 16, 2026
Upgrades: Buy
Price Target: $100 → $90
Current: $75.28
Upside: +19.55%
Eupraxia Pharmaceuticals
Mar 23, 2026
Initiates: Outperform
Price Target: n/a
Current: $7.06
Upside: -
Viridian Therapeutics
Dec 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $14.33
Upside: -
Manhattan Associates
Jun 10, 2025
Downgrades: Neutral
Price Target: $270 → $200
Current: $142.88
Upside: +39.98%
Harrow
Jun 10, 2025
Initiates: Outperform
Price Target: n/a
Current: $39.14
Upside: -
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $6.33
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $9.66
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $477.26
Upside: +25.72%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $331.61
Upside: +5.55%
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $40.89
Upside: -